These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12165656)

  • 1. Expression of Pit-1 and growth hormone-releasing hormone receptor mRNA in human pituitary adenomas: difference among functioning, silent, and other nonfunctioning adenomas.
    Kobayashi I; Oka H; Naritaka H; Sato Y; Fujii K; Kameya T
    Endocr Pathol; 2002; 13(2):83-98. PubMed ID: 12165656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas.
    Hashimoto K; Koga M; Motomura T; Kasayama S; Kouhara H; Ohnishi T; Arita N; Hayakawa T; Sato B; Kishimoto T
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2933-9. PubMed ID: 7559877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression.
    Pellegrini-Bouiller I; Morange-Ramos I; Barlier A; Gunz G; Figarella-Branger D; Cortet-Rudelli C; Grisoli F; Jaquet P; Enjalbert A
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3390-6. PubMed ID: 8784102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors.
    Lopes MB; Gaylinn BD; Thorner MO; Stoler MH
    Am J Pathol; 1997 Jun; 150(6):1885-91. PubMed ID: 9176381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.
    Nishioka H; Inoshita N; Mete O; Asa SL; Hayashi K; Takeshita A; Fukuhara N; Yamaguchi-Okada M; Takeuchi Y; Yamada S
    Endocr Pathol; 2015 Dec; 26(4):349-55. PubMed ID: 26481628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of growth hormone-releasing hormone receptor mRNA in non-neoplastic pituitary and pituitary adenomas: a study by RT-PCR and in situ hybridization.
    Oka H; Kameya T; Sato Y; Naritaka H; Kawano N
    J Neurooncol; 1999 Feb; 41(3):197-204. PubMed ID: 10359139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product.
    Sanno N; Teramoto A; Matsuno A; Osamura RY
    Arch Pathol Lab Med; 1996 Jan; 120(1):73-7. PubMed ID: 8554449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of GATA-2 in human pituitary adenomas.
    Umeoka K; Sanno N; Osamura RY; Teramoto A
    Mod Pathol; 2002 Jan; 15(1):11-7. PubMed ID: 11796836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies.
    Barlier A; Zamora AJ; Grino M; Gunz G; Pellegrini-Bouiller I; Morange-Ramos I; Figarella-Branger D; Dufour H; Jaquet P; Enjalbert A
    J Neuroendocrinol; 1999 Jul; 11(7):491-502. PubMed ID: 10444306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of growth-related factors in human pituitary adenomas. Lowered insulin-like growth factor-I and its receptor mRNA in growth hormone-producing adenomas.
    Otsuka F; Tamiya T; Yamauchi T; Ogura T; Ohmoto T; Makino H
    Regul Pept; 1999 Aug; 83(1):31-8. PubMed ID: 10498342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
    Kim K; Arai K; Sanno N; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
    Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and alternative splicing of Pit-1 messenger ribonucleic acid in pituitary adenomas.
    Hamada K; Nishi T; Kuratsu J; Ushio Y
    Neurosurgery; 1996 Feb; 38(2):362-6. PubMed ID: 8869065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas.
    Asa SL; Puy LA; Lew AM; Sundmark VC; Elsholtz HP
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1275-80. PubMed ID: 8077321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.
    Kim K; Arai K; Sanno N; Osamura RY; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):759-68. PubMed ID: 11422110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of an orphan nuclear receptor DAX-1 in human pituitary adenomas.
    Ikuyama S; Mu YM; Ohe K; Nakagaki H; Fukushima T; Takayanagi R; Nawata H
    Clin Endocrinol (Oxf); 1998 May; 48(5):647-54. PubMed ID: 9666878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Pit-1 mRNA and activin/inhibin subunits in clinically nonfunctioning pituitary adenomas. In situ hybridization and immunohistochemical analysis.
    Sanno N; Teramoto A; Sugiyama M; Matsuno A; Takumi I; Tahara S; Osamura RY
    Horm Res; 1998; 50(1):11-7. PubMed ID: 9691207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
    Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
    Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression study of thyrotropin releasing hormone (TRH) receptor using RT-PCR: relationship to clinical and immunohistochemical phenotypes in a series of human pituitary adenomas.
    Igarashi-Migitaka J; Yamada S; Hara M; Sano T; Ozawa Y; Ohtani-Kaneko R; Hirata K
    Endocr J; 2003 Aug; 50(4):459-67. PubMed ID: 14599121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.